Ferrannini E - Search Results

1

Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.

Rebelos E, Muscelli E, Natali A, Balkau B, Mingrone G, Piatti P, Konrad T, Mari A, Ferrannini E; RISC Study Investigators. Rebelos E, et al. Among authors: ferrannini e. Diabetes. 2011 Jul;60(7):1938-45. doi: 10.2337/db11-0217. Epub 2011 May 26. Diabetes. 2011. PMID: 21617179 Free PMC article.

2

Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.

Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E. Greco AV, et al. Among authors: ferrannini e. Diabetes. 2002 Jan;51(1):144-51. doi: 10.2337/diabetes.51.1.144. Diabetes. 2002. PMID: 11756334

3

Effect of acute hyperglycemia on insulin secretion in humans.

Toschi E, Camastra S, Sironi AM, Masoni A, Gastaldelli A, Mari A, Ferrannini E, Natali A. Toschi E, et al. Among authors: ferrannini e. Diabetes. 2002 Feb;51 Suppl 1:S130-3. doi: 10.2337/diabetes.51.2007.s130. Diabetes. 2002. PMID: 11815471 Clinical Trial.

4

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

Mari A, Tura A, Gastaldelli A, Ferrannini E. Mari A, et al. Among authors: ferrannini e. Diabetes. 2002 Feb;51 Suppl 1:S221-6. doi: 10.2337/diabetes.51.2007.s221. Diabetes. 2002. PMID: 11815483

5

Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Mari A, et al. Among authors: ferrannini e. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66. doi: 10.1152/ajpendo.00093.2002. Epub 2002 Aug 6. Am J Physiol Endocrinol Metab. 2002. PMID: 12388151 Free article. Clinical Trial.

6

Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.

Quiñones-Galvan A, Pucciarelli A, Ciociaro D, Masoni A, Franzoni F, Natali A, Ferrannini E. Quiñones-Galvan A, et al. Among authors: ferrannini e. J Cardiovasc Pharmacol. 2002 Dec;40(6):916-21. doi: 10.1097/00005344-200212000-00013. J Cardiovasc Pharmacol. 2002. PMID: 12451325 Clinical Trial.

7

Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets.

Marchetti P, Antonelli A, Lupi R, Marselli L, Fallahi P, Nesti C, Baj G, Ferrannini E. Marchetti P, et al. Among authors: ferrannini e. Diabetes. 2002 Dec;51 Suppl 3:S474-7. doi: 10.2337/diabetes.51.2007.s474. Diabetes. 2002. PMID: 12475792

8

Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality.

Natali A, L'Abbate A, Ferrannini E. Natali A, et al. Among authors: ferrannini e. Eur Heart J. 2003 Apr;24(7):639-48. doi: 10.1016/s0195-668x(02)00741-8. Eur Heart J. 2003. PMID: 12657222

9

Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertension.

Kozàkovà M, Morizzo C, Ferrannini E, Palombo C. Kozàkovà M, et al. Among authors: ferrannini e. J Hypertens. 2003 Jul;21(7):1407-14. doi: 10.1097/00004872-200307000-00032. J Hypertens. 2003. PMID: 12817191

10

Metabolic effects of antihypertensive treatment: long live the debate.

Ferrannini E, Kozàkovà M. Ferrannini E, et al. J Hypertens. 2003 Aug;21(8):1459-62. doi: 10.1097/00004872-200308000-00007. J Hypertens. 2003. PMID: 12872037 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters